Comparison of thrice daily insulin aspart and thrice daily insulin aspart 70/30 on glycemic control and safety in type 2 diabetes

Trial Profile

Comparison of thrice daily insulin aspart and thrice daily insulin aspart 70/30 on glycemic control and safety in type 2 diabetes

Completed
Phase of Trial: Phase II

Latest Information Update: 13 May 2016

At a glance

  • Drugs Insulin aspart/insulin protamine aspart (Primary) ; Insulin aspart
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Biomarker; Therapeutic Use
  • Most Recent Events

    • 03 Jun 2012 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan records.
    • 12 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top